Every year, U.S. health systems commit billions of dollars to high-stakes strategic initiatives. Organizations expand oncology networks, build ambulatory surgery platforms, launch digital health capabilities, redesign care models, and restructure pricing strategies to compete for growth and retention. The planning behind these investments is often exhaustive. Executive teams analyze historical claims data, review market share trends, commission research, conduct interviews, and hold focus groups among physicians and consumers.
Yet despite sophisticated planning processes, hospital and health system executives report that a significant percentage (70% as reported by McKinsey & Company) of strategic growth and transformation initiatives fail to achieve their intended outcomes. Referral leakage persists. Out-of-network migration continues. Newly built capacity remains underutilized. Strategic growth projections miss expectations.
The problem is rarely execution alone. The deeper issue is that most healthcare organizations are making forward-looking capital decisions using backward-looking data and traditional research methods that were never designed to predict real-world human behavior under changing market conditions.
The Healthcare Decision Blind Spot
Traditional healthcare analytics are optimized to explain what already happened—not to predict what consumers and physicians will choose next when presented with new options, incentives, or tradeoffs. Claims data, utilization reports, market share studies, and retrospective dashboards are valuable operational tools. Still, they possess a fundamental limitation: they cannot reliably forecast how physicians, patients, employers, or employees will behave in response to a market that does not yet exist.
Conventional market research approaches, including surveys, focus groups, and stated-intent interviews, often yield misleading confidence levels. Healthcare leaders, therefore, face a critical strategic blind spot: They are allocating capital based on assumptions about future human decisions that have never been behaviorally tested.
Referral Reality: The 80% Gatekeeper
One of the clearest examples emerges in the specialty care growth strategy.
Health systems frequently design expansion initiatives around patient acquisition assumptions—investing heavily in branding, digital engagement, consumer marketing, and price transparency. However, MII’s behavioral decision intelligence work consistently reveals a different operational reality: for many high-value specialty services, the referring physician still controls about 80% of referral volume depending on the specialty and complexity of care. As a result, a health system may invest in optimizing the patient experience while failing to address behavioral drivers that influence the physician who controls referral direction. This is not a marketing problem. It is a decision architecture problem.
Retrospective Data Cannot Predict Novel Market Conditions
Historical claims and utilization data describe yesterday’s market structure. They cannot reliably predict how stakeholders will respond to:
-
- A newly launched service line
- A redesigned incentive structure
- A digital-first care model
- A competitor entering the market
- A new referral pathway
- A change in scheduling velocity
- Modified site-of-care economics
Historical conditions inherently constrain retrospective data. But a healthcare strategy requires predicting future choices under conditions that do not yet exist.
Replacing Strategic Guessing with Behavioral Decision Intelligence
Healthcare leaders cannot eliminate market uncertainty. But they can significantly reduce strategic blind spots. By designing behavioral experiments that simulate real-world stakeholder decisions before launch, organizations can:
-
- Predict adoption behavior more accurately
- Test strategic assumptions
- Identify hidden referral friction
- Optimize service-line design
- Improve capital allocation decisions
- Reduce avoidable strategic failure
- Align operational design with actual human behavior
The future of healthcare strategy will not belong to organizations with the largest dashboards of retrospective data. It will belong to organizations capable of experimentally modeling human behavior before capital is deployed. Before launching your next strategic initiative, the critical question is no longer: “What does the historical data say?”